Comparison of SARS-CoV-2 Antibody Levels after a Third Heterologous and Homologous BNT162b2 Booster Dose

Comparison of SARS-CoV-2 Antibody Levels after a Third Heterologous and Homologous BNT162b2 Booster Dose

This study aimed to determine the anti-S (receptor binding protein) RBD IgG antibody titers formed against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2) and the neutralizing antibody inhibition percentages (nAb IH%) in blood samples taken after two doses of inactive or mRNA-based vacci...

Full description

Bibliographic Details
Main Authors: Nesrin Gareayaghi, Mehmet Demirci, Dogukan Ozbey, Ferhat Dasdemir, Harika Oyku Dinc, Ilker Inanc Balkan, Suat Saribas, Neşe Saltoglu, Bekir Kocazeybek
Format: Article
Language:English
Published: MDPI AG 2022-10-01
Series:Vaccines
Subjects:
CoronaVac
BNT162b2
neutralizing antibody
binding antibody
Online Access:https://www.mdpi.com/2076-393X/10/10/1672

Internet

https://www.mdpi.com/2076-393X/10/10/1672

Similar Items